In drug development, assay development aims on delivering specific procedures to assess a compound or examine a compound’s effects on the identified cellular or biochemical targets. Therefore, it is an integral step in the drug discovery process, where significant effort and cost savings are incurred when robust assay development can screen out non-viable candidates early in the process. Often tens of thousands of compounds need to be screened using specifically designed biochemical or cell-based assays. Thus, it is important to have a flexible platform for a large range of assays. CELLINK provides key instrumentation for efficient, high- throughput assay development, including solutions for highly multiplexed low-volume liquid handling, automated live cell imagers, and a variety of bioprinters to create 3D cell cultures, which have better representation of activity response than 2D.